Showing 1 - 10 of 392,467
explored in an in-depth qualitative examination of sourcing practices in drug development. The outsourcing of central … biotechnology firms, I explain why outsourcing deals take the form of embedded relationships in the first setting, and of seemingly …
Persistent link: https://www.econbiz.de/10012468552
explored in an in-depth qualitative examination of sourcing practices in drug development. The outsourcing of central … biotechnology firms, I explain why outsourcing deals take the form of embedded relationships in the first setting, and of seemingly …
Persistent link: https://www.econbiz.de/10013239192
Persistent link: https://www.econbiz.de/10009303719
Persistent link: https://www.econbiz.de/10003855656
Persistent link: https://www.econbiz.de/10001825856
Persistent link: https://www.econbiz.de/10003955273
mit einem attraktiven Partner aus der Pharmaindustrie unter Beweis stellen. Ohne dieses Gütesiegel sind auch die …
Persistent link: https://www.econbiz.de/10002146234
Persistent link: https://www.econbiz.de/10011506049
This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...
Persistent link: https://www.econbiz.de/10011372508
Prior research on corporate headquarters (CHQ) characteristics identifies the impact of CHQ location and composition on the innovation outcomes of internal subsidiaries. However, given that external strategic alliances with high-tech entrepreneurial firms represent a key source of innovation for...
Persistent link: https://www.econbiz.de/10012131396